Differentiation of endothelial progenitor cells: A useful biomarker?

Circulation Journal

Volumn 73, Issue 7, 2009, Pages 1199-1200

  Yasu, Takanori ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; CD133 ANTIGEN; CD34 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VASCULOTROPIN RECEPTOR 2;

ATHEROSCLEROSIS; BLOOD VESSEL FUNCTION; BLOOD VESSEL INJURY; CARDIOVASCULAR RISK; CELL COUNT; CELL DIFFERENTIATION; COLONY FORMING UNIT; CORONARY ARTERY DISEASE; DISEASE MARKER; EDITORIAL; ENDOTHELIAL PROGENITOR CELL; EXERCISE; FLOW CYTOMETRY; HUMAN; NEOVASCULARIZATION (PATHOLOGY); PROTEIN BLOOD LEVEL; STEM CELL; VASCULAR ENDOTHELIUM; VASODILATATION;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; CELL PROLIFERATION; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; HUMANS; MALE; MESENCHYMAL STEM CELLS;

EID: 68149166458     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0363     Document Type: Editorial

References (15)

1. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27.
2. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801-809.
3. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J 2009; 73: 411-418.
4. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967. (Pubitemid 27087709)
5. Hristov M, Weber C. Endothelial progenitor cells: Characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 2004; 8: 498-508. (Pubitemid 44145482)
6. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al, Therapeutic angiogenesis using cell transplantation (TACT) study investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. Lancet 2002; 360: 427-435.
7. Yoshioka T, Ageyama N, Shibata H, Yasu T, Misawa Y, Takeuchi K, et al. Repair of infarcted myocardium mediated by transplanted bone marrow-derived CD34+ stem cells in a nonhuman primate model. Stem Cells 2005; 23: 355-364. (Pubitemid 40404454)
8. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyymi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600. (Pubitemid 36204953)
9. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007. (Pubitemid 41262334)
10. Vasa M, Fichtischerer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-E7.
11. Xiao Q, Klechl S, Petel S, Oberhollenzer F, Weger S, Mayr A, et al. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis: Results from a large population-based study. PLoS One 2007; 2: e975, 1-9.
12. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104: 2752-2760. (Pubitemid 39434958)
13. + cell after myocardial infarction treated by bare metal stent implantation. Circ J 2008; 72: 897-901. (Pubitemid 351888257)
14. Miura M, Numaguchi Y, Ishii M, Kubota R, Takeuchi T, Imamura A, et al. Differentiation capacity of endothelial progenitor cells correlates with endothelial function in healthy young men. Circ J 2009; 73: 1324-1329.
15. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 2003; 107: 499-511.